New research reveals that patients with stable coronary artery disease who quit smoking at any point after diagnosis can reduce their risk of major cardiovascular events by nearly 50%. The study, presented at ESC Congress 2024, also found that merely reducing smoking habits had minimal impact on cardiovascular risk.
A series of groundbreaking studies from Poland have shed new light on the prevalence and impact of lipoprotein(a) [Lp(a)] on cardiovascular health, prompting calls for routine measurement of this important biomarker.
A novel genetic scoring system developed by researchers at NYU Grossman School of Medicine could revolutionise the detection of platelet hyperreactivity, offering a more precise method to identify patients at risk of heart attacks and strokes.
A study published in JAMA estimates that adopting new cardiovascular disease risk prediction equations could make nearly 16 million fewer US adults eligible for preventive medications, potentially leading to over 100,000 additional occurrences of myocardial infarction or stroke over 10 years.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
